Skip to Content

User Reviews for Glimepiride / pioglitazone systemic

Also known as: Duetact

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Condition	Avg. Ratings		Reviews	Compare
Diabetes, Type 2	10		1 review	145 medications

Reviews for Glimepiride/pioglitazone

For Diabetes, Type 2: "good experience."

10

welman (taken for 10 years or more) November 5, 2015

0 users found this comment helpful.
Did you? Yes No | Report inappropriate

Learn more about

IBM Watson Micromedex

Drugs.com Health Center

Mayo Clinic Reference

More about glimepiride/pioglitazone

Consumer resources

Other brands: Duetact

Professional resources

Related treatment guides

Diabetes, Type 2

Drug Status

Rx

Availability Prescription only

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Manufacturers

Drug Class

Antidiabetic combinations

Related Drugs

Diabetes, Type 2 metformin, Victoza, Trulicity, Lantus, Tresiba, Levemir, Novolog, Bydureon, Basaglar, Toujeo, insulin aspart, Soliqua, Admelog, Xultophy, Tanzeum, Adlyxin, glipizide, Januvia, glimepiride, pioglitazone, Tradjenta, Jardiance, Invokana, Actos, More...

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions and Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com Discount Card

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated Dec 6th, 2018), Cerner Multum™ (updated Dec 7th, 2018), Wolters Kluwer™ (updated Dec 5th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.